Related Experiment Video

Updated: Jun 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Hematopoietic stem cell transplantation for chronic granulomatous disease

Reinhard A Seger1

  • 1Division of Immunology/Hematology/BMT, University Children's Hospital, Steinwiesstrasse 75, Zürich 8032, Switzerland. Reinhard.Seger@kispi.uzh.ch

Immunology and Allergy Clinics of North America
|May 25, 2010
PubMed

Insights

Chronic granulomatous disease (CGD) is an immunodeficiency treated by hematopoietic stem cell transplantation (HSCT). HSCT offers a cure for CGD, but patient selection remains challenging due to variable disease courses and improved supportive care.

Area of Science:

  • Immunology
  • Hematology
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency.
  • It results from a defect in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex.
  • This defect impairs the ability of neutrophils, macrophages, and eosinophils to produce superoxide.

Purpose of the Study:

  • To review recent advancements in allogeneic hematopoietic stem cell transplantation (HSCT) for CGD.
  • To identify current challenges and limitations in HSCT for CGD.
  • To discuss future directions and developments in CGD treatment.

Main Methods:

  • Literature review of recent studies on HSCT for CGD.
  • Analysis of clinical outcomes and patient selection criteria for HSCT.
  • Discussion of supportive care and disease variability in CGD.

Main Results:

  • Allogeneic HSCT is the only known curative treatment for CGD.
  • Improved supportive care has led to better outcomes, complicating HSCT eligibility assessment.
  • Clinical variability in disease progression presents challenges in selecting patients for HSCT.

Conclusions:

  • HSCT remains a crucial curative option for selected CGD patients.
  • Further research is needed to refine patient selection criteria for HSCT.
  • Future developments may enhance HSCT efficacy and accessibility for CGD.

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...